Company news
Catalyst Pharmaceuticals, Inc. news in 2019
Catalyst Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.
Catalyst Pharmaceuticals to Participate in the Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019
Catalyst Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 11, 2019
Catalyst Pharmaceuticals to Hold Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, November 13th, 2019
October 30, 2019
Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS)
October 29, 2019
Catalyst Pharmaceuticals to Participate in the 2019 Cantor Global Healthcare Conference
September 24, 2019
Catalyst Pharmaceuticals, Inc. Comments on Trading in its Common Stock and on its Capital Resources
September 22, 2019
Catalyst Pharmaceuticals, Inc. Determines Not to Proceed with Previously Announced Public Offering of Common Stock
September 12, 2019